Kristiyana Kaneva

Assessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy

Charu Aggarwal, Rotem Ben-Shachar, Yinjie Gao et al. · JAMA Network Open · 2023 · 107 citations · Full text

INFINITY: A multicentre, single-arm, multi-cohort, phase II trial of tremelimumab and durvalumab as neoadjuvant treatment of patients with microsatellite instability-high (MSI) resectable gastric or gastroesophageal junction adenocarcinoma (GAC/GEJAC).

Filippo Pietrantonio, Alessandra Raimondi, Sara Lonardi et al. · Journal of Clinical Oncology · 2023 · 90 citations

Surgical Oncology, Cancer Management, Immunology +22

Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO

A. Raimondi, Sara Lonardi, Sabina Murgioni et al. · Annals of Oncology · 2024 · 50 citations

Surgical Oncology, Esophageal Cancer, Gastrointestinal Oncology +10

Landscape of Germline and Somatic Mitochondrial DNA Mutations in Pediatric Malignancies

Petr Tříska, Kristiyana Kaneva, Daria Merkurjev et al. · Cancer Research · 2019 · 48 citations · Full text

Racial Disparities in Pathological Complete Response Among Patients Receiving Neoadjuvant Chemotherapy for Early-Stage Breast Cancer

Fangyuan Zhao, Minoru Miyashita, Masaya Hattori et al. · JAMA Network Open · 2023 · 30 citations · Full text